Genex Pharmaceutical, Inc.

FRC's fair value estimate for Genex Pharmaceutical, Inc., and the rating behind it. GENX last traded at $0.0001, 0.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Valuation, profitability, liquidity and leverage ratios for Genex Pharmaceutical, Inc.. Starting points for Genex Pharmaceutical, Inc.: P/E 0.0, EPS $0.02, beta -0.48 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend history, yield and payout sustainability for Genex Pharmaceutical, Inc.. Genex Pharmaceutical, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Reported vs. expected earnings history for Genex Pharmaceutical, Inc.. Trailing twelve-month EPS for Genex Pharmaceutical, Inc. stands at $0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Income statement, balance sheet and cash flow history for Genex Pharmaceutical, Inc.. Genex Pharmaceutical, Inc. has reported as a listed company since 2004. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Genex Pharmaceutical, Inc. valued side by side against its closest peers. Genex Pharmaceutical, Inc. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Which institutions hold Genex Pharmaceutical, Inc., and how their positions are changing. At a $1,788 market value, institutional positions materially move Genex Pharmaceutical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Buying and selling by Genex Pharmaceutical, Inc. executives and directors. Shares of Genex Pharmaceutical, Inc. have traded between $0.0001 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

U.S. Senate disclosures naming Genex Pharmaceutical, Inc.. Genex Pharmaceutical, Inc. is a $1,788 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

U.S. House of Representatives disclosures naming Genex Pharmaceutical, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

Latest headlines and company announcements for Genex Pharmaceutical, Inc.. Coverage tracks Genex Pharmaceutical, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.